Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data
Vitroscope, a biotech company developing perfusion platforms to study immune activity, treatment responses and disease mechanisms in real time, has raised $7 million, comprising a $5 million seed roun...
We haven't written up this one. Tech.eu has the full story — the link below goes straight to it.